Leitlinien zur Diagnostik und Therapie der tiefen Bein-/Beckenvenenthrombose

Phlebologie

Volumn 27, Issue 3, 1998, Pages 84-88

  Blattler W ^a   Partsch, H ^a   Hertel, T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002178785     PISSN: 0939978X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1616953     Document Type: Article

References (44)

1. Weinmann EE, Salzman EW. Deep-vein thrombosis. N Engl J Med 1994; 331: 1630-41.
2. Hirsh J. Heparin. N Engl J Med 1991; 324: 1565-74.
3. Comerota AJ, Aldridge SC. Thrombolytic therapy for deep venous thrombosis: a clinical review. Can J Surg 1993; 36: 359-64.
4. Brandjes DPM, Biiller HR, ten Gate JW. et al. Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis. Lancet 1997; 349: 759-62.
5. Wheeler HB, Hirsh J. Wells P, Anderson FA. Diagnostic tests for deep vein thrombosis. Arch Intern Med 1994: 154: 1921-8.
6. Wells PS. Hirsh J. Anderson DR. Lensing AWA et al. Accuracy of clinical assessment of deep-vein thrombosis. Lancet 1995; 345: 1326-30.
7. Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemostat 1994; 71: 1-6.
8. Wells PS, Brill-Edwards P, Stevens P. et al. A novel and rapid whole blood assay for Ddimer in patients with clinically suspected deep vein thrombosis. Circulation 1995; 91: 2184-7.
9. John MA, Elms MJ, O'Reilly EJ, et al. The simpliRED D-dimer test: a novel assay for the detection of cross-linked fibrin degradation products in whole blood. Thromb Res 1990;58:273-81.
10. Meyerovitz MF. Polak JF. Goldhaber SZ. Short-term response to thrombolytic therapy in deep venous thrombosis: predictive value of venographic appearance. Radiology 1992:184:345-8.
11. O'Meara JJ, McNutt RA, Evans AT, et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deepvein thrombosis. N Engl J Med 1994; 330: 1864.
12. The Columbus Investigators. Low-molecular-weight heparin in the treatment of patients with venous thromboembolism. N Engl J Med 1997; 337: 657-62.
13. Simmoneau G, Sors H. Charbonnier B, Page Y. et al. A comparison of low-molecularweight heparin with unfractionated heparin for acute pulmonary embolism. N Engl J Med 1997:337:663-9.
14. Harenbcrg J. Schmitz-Huebner U. Therapie der Beinvenenthrombose mit niedermolekularen Heparinen. Deutsches Ärzteblatt 1997; 94: 2257-60.
15. Diuguid DL. Oral anticoagulant therapy for venous thromboembolism. N Engl J Med 1997;336:433-4.
16. Rosendaal FR. The scylla and charybdis of oral anticoagulant treatment. N Engl J Med 1996:335:587-9.
17. Raschke RA, Reilly BM, Guidry JR, et al. The weight-based heparin dosing nomogram compared with "standard care" nomogram. Ann Intern Med 1993; 119: 874-81.
18. Hommes DW, Bura A, Mazzolai L, et al. Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysis. Ann Int Med 1992; 116: 279-84.
19. Bounameaux H. Medikamentöse Therapie der tiefen Venenthrombose. Ther Umschau 1996:53:272-6.
20. Partsch H. Compression therapy of legs. J Dermatol Surg Oncol 1991: 17: 799-8Ü5.
21. Vin F. Compression et thrombose veineuse profonde. Phlébologie 1994; 47: 35-9.
22. Blättler W. Ambulatory care for ambulant patients with deep vein thrombosis. J Malad Vase 1991; 16: 137-41.
23. Blättler W. Borer M. Under C, Bergan JJ. Outpatient and conventional treatment of acute deep-vein thrombosis evaluated in a controlled single-center study. Phlébologie 1988:51:41-6.
24. Levine M. Gent M, Hirsh J, et al. A comparison of low-molecular-weight heparin administered primarily at home with unfractionated heparin administered in the hospital for proximal deep-vein thrombosis. N Engl J Med 1996; 334: 677-81.
25. Koopman MMW. Prandoni P, Piovella F et al. Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. N Engl J Med 1996; 334:677-81.
26. Partsch H, Oburger K, Mostbeck A, König B, Kühn H. Frequency of pulmonary embolism in ambulant patients with pelvic vein thrombosis: A prospective study. J Vase Surg 1992; 16: 715-22.
27. Baldridge ED, Martin MA, Welling RE. Clinical significance of free-floating venous thrombi. J Vase Surg 1990; 11: 62-9.
28. Pacouret G, Lison D, Charbonnier B, Augusseau MP, Pottier JM. Free floating thrombus and embolie risk in patients with angiographically established proximal deep venous thrombosis. A prospective study. Phlebology 1995; Suppl 1: 658-60.
29. Schafer AI. Low-molecular-weight heparin an opportunity for home treatment of venous thrombosis. N Engl J Med 1996; 334: 724-5.
30. Blättler W, Frick E. Ambulante oder stationäre Behandlung der akuten tiefen Beinvenenthrombose: die Präferenzen der
31. Patienten. Schweiz Med Wschr 1996; 126 (Suppl 74/1): 22S.
32. Mostbeck A. Partsch H, Köhn H, König B. Lungenembolie bei Bein-Beckenvenenthrombose: Ergebnisse einer prospektiven Studie. Wien Klin Wschr 1980; 92: 464-71.
33. Huisman MV. Büller HR. ten Gate JW, et al. Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis. Chest 1989; 95: 498-502.
34. Décousus H, Leizorovicz A, Parent F, et al. A clinical trial of vena cava filters in the prevention of pulmonary embolism in patients with proximal deep-vein thrombosis. N Engl J Med 1998; 338: 409-15.
35. Prandoni P, Lensing AW A, Büller HR, Cogo A, et al. Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 1992, 327: 1128-33.
36. Nordström M, Lindblad B, Anderson H, et al. Deep venous thrombosis and occult malignancy: an epidemiological study. Br MedJ 1994; 308: 891-4.
37. Netzer P, Lazarevic, Hammer B. Wert des Abdomenultraschalls bei tiefer Venenthrombose. Schweiz Med Wschr 1996; 126: 58S-63S.
38. Research Committee of the British Thoracic Society. Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolism. Lancet 1992: 340: 873-6.
39. Sarasin FP, Bounameaux H. Duration of anticoagulant therapy after proximal deep vein thrombosis: a decision analysis. Thromb Haemost 1994; 71: 286-91.
40. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-5.
41. Schulman S, Granqvist S, Holmström M, et al. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. N Engl J Med 1997; 336: 393-8.
42. Koster T, Small RA, Rosendaal FR, Heimerhorst FM. Oral contraceptives and venous thromboembolism: a quantitative discussion of the uncertainties. J Intern Med 1995:238:31-7.
43. Weiss N. Third-generation oral contraceptives: how risky? Lancet 1995; 346: 1570.
44. Devor M, et al. Estrogen replacement therapy and the risk of venous thrombosis. Am J Med 1992; 92: 275-82.